Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Frontiers in Immunology|September 8, 2025
Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clonesYun Liu, Dzmitry Padhorny, Rosa Catera, et al.Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.Blood|May 17, 2003
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B StudyClaudia D Baldus, Stephan M Tanner, Amy S Ruppert, et al.Blood|January 1, 2015
Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsR Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al.Molecular Medicine (Cambridge, Mass.)|October 5, 2011
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cellsCarlo Calissano, Rajendra N Damle, Sonia Marsilio, et al.Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.Blood|December 19, 2015
Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitorsBrian M Dulmovits, Abena O Appiah-Kubi, Julien Papoin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRichard L Piekarz, Robin Frye, Maria Turner, et al.Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.British Journal of Haematology|April 21, 2015
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataSusan E Bates, Robin Eisch, Alexander Ling, et al.Pageof 9